Announced Thu, 9 Jul · 18:36 IST
Promoters confirm no new share encumbrances for FY25
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹526.90
prior close
₹525.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4-0.2-0.2+1.0+0.6-1.1-2.3-2.8-8.0-11.3————
Up moveDown movePending
AI summary
Bliss GVS Pharma's promoters and promoter group filed their yearly disclosure under SEBI Takeover Regulations for FY ended March 31, 2025. Together they hold 3,71,22,024 shares (35.23% stake). All members declared no new encumbrances on shares during the year and confirmed encumbered shares stand at nil. This is a routine annual compliance filing.
Likely market impact
Routine compliance update with no impact on shares. Promoter holding at 35.23% remains below the 50% threshold.